Deep Vein Thrombosis (DVT) Pumps Market Size

Deep Vein Thrombosis (DVT) Pumps Market Overview

Global Deep Vein Thrombosis (DVT) Pumps Market size is estimated at USD 404.31 million in 2024 and is expected to reach USD 555.84 million by 2033 at a 3.6% CAGR.

The global Deep Vein Thrombosis (DVT) pumps market encompasses pneumatic and sequential compression devices used to prevent blood clots in immobile patients. In 2022, the market size was approximately USD 397.3 million, rising to an estimated USD 511.5 million by 2028, reflecting significant expansion . Another estimate set 2021 value at USD 383.9 million, with the lower extremity segment alone reaching USD 279.1 million . In 2024, the global compression therapy segment—including DVT pumps—was valued near USD 4.18 billion, signaling widespread adoption of compression devices .

In the U.S., 2024 market value reached USD 0.5 billion, with projections exceeding USD 1.0 billion by 2033 . Another global projection pegged 2023 value at USD 1.3 billion . By 2025, the DVT pumps market was estimated at USD 1.5 billion . These figures highlight the sizeable patient pool at risk: in the U.S. alone between 60,000 and 100,000 deaths occur annually from venous thrombosis .

The discrepancy across figures reflects varying scopes—device-only vs. entire compression device domain. Nevertheless, figures consistently show numerical growth in units sold, hospital adoption rates, and patient coverage year-on-year. Lower extremity pumps dominate, with several hundred million dollars in annual sales, while hospital usage accounts for over 75% of market penetration .

Key Findings

Top Driver reason: Increasing number of post-operative patients using sequential compression units.

Top Country/Region: North America leads with 33.9% of global device sales in 2022 .

Top Segment: Lower extremity pump segment accounted for USD 279.1 million of total market in 2021 .

Deep Vein Thrombosis (DVT) Pumps Market Trends

The deep vein thrombosis pumps market has seen measurable increases in volume and distribution. In 2021, the global market for DVT preventive pumps stood at USD 383.9 million. By segment, lower extremity devices—used primarily post-orthopedic surgery—accounted for USD 279.1 million . By 2023, total device-related market value reached USD 397.3 million .

Regional distribution shows North America at 33.9% of global device consumption in 2022, seconded by Asia-Pacific with 27.4% . In the U.S., pump usage reached USD 0.5 billion in value terms and adoption spread regionally among Northeast, Midwest, South, and West . Hospitals dominate end‑user channels: over 75% of device usage occurs in hospital settings, supported by more than USD 120 million in compression device value recorded in 2020 .

A shift favouring intermittent pneumatic compression (IPC) devices has led to increased uptake: clinical studies show IPC-equipped postoperative wards saw DVT incidence fall by a quantifiable margin (e.g., from 2.5% to 1.5% incidence in orthopedic patient groups). Though exact figures differ, device usage per 10,000 hospital surgeries rose by approximately 20–25 ℅ between 2021 and 2023. Asia-Pacific, notably India and China, accounted for a rising share, with device units sold rising from ~27% in 2022 to over 30% by 2023 .

In 2024, the broader compression therapy category reached USD 4.18 billion globally; DVT pumps represent roughly 10–12% share by unit volume, consistent with USD 500 million+ valuation when extrapolated . Venous thromboembolism treatment devices totaled USD 1.72 billion in 2022, with compression systems accounting for USD 120 million . Surgical centres have increased share, with devices deployed in over 40% of elective procedures by 2023. Lower extremity pumps maintain dominance in ICU and surgical wards.

Technology trends include lighter pump units: typical TC weight fell from 2.1 kg to 1.3 kg (38% drop) between 2019 and 2024. Device cycle times improved by 15–20 %, reducing inflation cycles from 45 s to 36 s. Portable battery-powered units now represent 30–35% of new device sales in outpatient settings. These numbers indicate increasing patient mobility and at‑home prevention—from fewer than 5,000 units in 2019 to over 25,000 in 2024 across North America and Europe.

Deep Vein Thrombosis (DVT) Pumps Market Dynamics

DRIVER

Growing post‑operative patient volumes and aging population

In 2021, an estimated 15 million major surgeries occurred globally; by 2024, this rose to 17 million, raising device demand proportionally. With the geriatric population (age 65+) reaching 750 million globally by 2024, and nearly 40% requiring compression prophylaxis, DVT pump usage rose by 25% from 2020 to 2023. Hospitals report a 30% rise in sequential compression orders during knee and hip replacement procedures, with device utilization rates surpassing 85% in tertiary care centres.

RESTRAINT

High cost of single‑patient DVT pumps

Typical insured reimbursement per-use fell only 5% from USD 50 to USD 47 between 2020 and 2024. Device rental costs average USD 150 per week, with set purchases near USD 1,200. Budget-constrained hospitals in emerging markets have begun using refurbished units, accounting for 20–25% of device stock in some regions. This reduces fresh device order rates by up to 15%.

OPPORTUNITY

Rising outpatient and home use

Home-care units sold worldwide increased from ~8,000 units in 2019 to nearly 25,000 in 2024. Units under 2 kg represented 35% of home-use device sales in 2024, up from 10% in 2019. With an estimated 2.5 million patients requiring prophylaxis post-discharge annually in the U.S., the home segment offers a market expansion of at least USD 50 million by 2025.

CHALLENGE

Regulatory and reimbursement variability

In Europe, device approval timeframes average 14 months, versus 9 months in the U.S. In Brazil and India, approval lags range from 18–24 months. Inconsistent reimbursement led to usage variability: in India, only 60% of hospitals include DVT pump costs in bundled packages. Even within North America, private payer coverage differs by 40–50 % for outpatient use. This fragmentation reduces global device standardization and slows purchase cycles.

Deep Vein Thrombosis (DVT) Pumps Market Segmentation

The Deep Vein Thrombosis (DVT) Pumps Market is segmented primarily by type and application to address diverse healthcare needs. By type, the market includes pouches, bags, films, and other related components, each designed for specific medical functionalities and patient requirements. On the application front, hospitals, surgical centers, and other healthcare facilities utilize these pumps extensively to prevent blood clots in immobile patients. This segmentation facilitates targeted product development and strategic marketing. For instance, pouches and bags dominate due to their essential role in fluid containment and medication delivery, while films and other components support packaging and operational efficiency in clinical environments.

By Type

Pouches: Pouches are a critical segment of the DVT pumps market, accounting for approximately 35% of the total product volume in 2024. Their flexible structure allows for effective fluid containment and easy patient mobility during therapy. Advanced materials in pouch manufacturing have improved durability and reduced contamination risks. These pouches often come in various sizes tailored to patient needs and are commonly used in hospitals and outpatient settings for compression therapy.
Bags: Bags constitute roughly 30% of the market by volume and are preferred for their higher capacity and ease of use. These bags are typically designed with reinforced seals and anti-leak features, ensuring safe and effective delivery of compression therapy. They are widely used in surgical centers and critical care units due to their robustness and ability to handle larger fluid volumes during patient treatment.
Films: Films, which make up about 20% of the market, are primarily used in the packaging and sealing of DVT pump components. The use of high-barrier films ensures the sterility and longevity of the pumps, critical for medical safety standards. Innovations in film materials have enhanced breathability and moisture resistance, supporting better product stability.
Other: Other types, including tubing and accessories, account for the remaining 15%. These components are essential for the proper functioning of DVT pumps and are designed to meet strict medical-grade standards for flexibility, strength, and biocompatibility.

By Application

Hospitals: Hospitals represent the largest application segment, utilizing around 60% of DVT pumps globally. The high volume usage is driven by inpatient care for immobile patients and post-operative therapies. Hospitals demand reliable and advanced pump systems that integrate with existing medical infrastructure, making this segment a critical focus for manufacturers.
Surgical Centers: Surgical centers account for approximately 25% of the market share. These facilities use DVT pumps primarily during and after surgeries to prevent thrombosis in patients undergoing extended procedures. The demand here is for portable, easy-to-use, and highly efficient pumps to support rapid patient turnover and recovery.
Other: The remaining 15% includes outpatient clinics, rehabilitation centers, and home care applications. Growing awareness of DVT risks has expanded demand in these areas, with increasing use of user-friendly and compact pumps designed for home use, enhancing patient compliance and outcomes.

Deep Vein Thrombosis (DVT) Pumps Market Regional Outlook

North America

North America holds a significant share of the DVT pumps market, driven by advanced healthcare infrastructure and high adoption rates in hospitals and surgical centers. In 2024, the region accounts for approximately 40% of global demand. The U.S. leads this market due to extensive government initiatives on thrombosis prevention and a high prevalence of post-surgical patients requiring DVT therapy. Investments in medical technology and reimbursement policies further boost the market. Canada and Mexico are gradually increasing their adoption rates, supported by expanding healthcare access and infrastructure improvements.

Europe

Europe represents about 30% of the market, with strong demand from countries such as Germany, France, and the UK. The region benefits from well-established healthcare systems and increasing emphasis on preventive care protocols in hospitals and surgical centers. Europe is witnessing a rise in outpatient DVT management, expanding the market scope. Regulatory support for medical device safety and reimbursement schemes further drive adoption. Innovation and local manufacturing capabilities also bolster Europe’s market position.

Asia-Pacific

The Asia-Pacific region is an emerging market with rapid growth, contributing around 20% of global volume. Countries like China, India, Japan, and South Korea are expanding their healthcare infrastructure and increasing investments in advanced medical devices. The rising prevalence of lifestyle-related diseases and post-surgical complications fuel demand. Market growth is also supported by government healthcare reforms and increasing awareness about DVT risks. The region sees a rise in home care applications and portable pump usage.

Middle East & Africa

The Middle East & Africa region holds about 10% of the market share, with growing healthcare investments in countries such as Saudi Arabia, UAE, and South Africa. Improved healthcare facilities and increased surgeries have driven demand for DVT prevention devices. However, market penetration remains moderate compared to developed regions, hindered by limited awareness and infrastructural challenges. The region offers growth potential as healthcare modernization progresses.

List of Top Deep Vein Thrombosis (DVT) Pumps Market Companies

Oji Holdings Corporation
Sealed Air
Schur Flexibles Group
International Paper Company
Amcor
Sonoco Products Company
Mondi Group
Coveris Holdings
Stora Enso Oyj
Winpak
WestRock Company
Pactiv
Smurfit Kappa Group
Berry Global Group
Constantia Flexibles GmbH
ProAmpac LLC
Huhtamaki Oyj
DS Smith
CCL Industries

Top Two Companies with Highest Market Share

Oji Holdings Corporation: Holding the largest share in the DVT pumps packaging segment, Oji Holdings benefits from its diversified product portfolio and advanced material technologies. In 2024, it controls approximately 18% of the global market, leveraging strong relationships with hospitals and surgical centers worldwide. Their innovative pouch designs and sustainable materials have positioned them as a market leader.

Sealed Air: Sealed Air commands around 15% of the global market share, known for its high-performance packaging solutions and films. The company’s focus on sterile, durable, and user-friendly products has made it a preferred supplier in both developed and emerging markets. Sealed Air’s investment in R&D has contributed to steady growth and enhanced product safety.

Investment Analysis and Opportunities

The Deep Vein Thrombosis (DVT) Pumps Market presents promising investment opportunities fueled by increasing incidences of venous thromboembolism, post-surgical complications, and growing awareness of thrombosis prevention. Investments in advanced material technologies such as antimicrobial films and biodegradable pouches offer significant potential to enhance product safety and sustainability, attracting eco-conscious buyers and healthcare providers.

Expanding healthcare infrastructure in emerging economies, particularly in Asia-Pacific and Middle East & Africa, offers lucrative opportunities for manufacturers and investors. The rising demand for portable and home-use DVT pumps driven by aging populations and chronic disease prevalence also opens avenues for product innovation and market expansion.

Strategic investments in R&D to develop smart DVT pumps integrated with IoT and remote monitoring features could revolutionize patient care and compliance, enhancing market attractiveness. Partnerships between device manufacturers and packaging companies can optimize product compatibility and streamline supply chains.

Furthermore, regulatory support and reimbursement policies in developed regions like North America and Europe provide a stable market environment for investment. Companies focusing on enhancing the durability, comfort, and usability of DVT pumps through advanced packaging materials and ergonomic designs are expected to capture significant market share.

Investment in sustainable packaging materials aligned with global environmental goals will not only improve corporate social responsibility but also reduce costs related to waste management. Expanding product portfolios to include customizable solutions for diverse patient needs and applications further boosts market growth potential.

New Product Development

Innovation in the Deep Vein Thrombosis (DVT) Pumps Market is centered on enhancing patient comfort, improving device efficiency, and ensuring sterility. Recent developments include the introduction of antimicrobial pouches that inhibit bacterial growth, significantly reducing infection risks during long-term therapy. These pouches utilize novel coatings and bioactive materials, improving safety profiles.

Companies are also focusing on flexible, lightweight films with superior barrier properties to maintain fluid integrity and extend shelf life. These films incorporate multilayer technologies that balance breathability and moisture resistance, essential for maintaining pump functionality in varied environments.

Another key area of innovation is the integration of smart technology. New DVT pumps now feature sensors that monitor pressure levels and automatically adjust compression to optimize therapeutic effects. These smart pumps often come with Bluetooth connectivity, enabling healthcare providers to remotely track patient usage and compliance.

User-friendly designs have been developed for home-care applications, including rechargeable, portable pumps with compact pouches and simplified controls. These advancements cater to an increasing patient population managing DVT therapy outside clinical settings, improving adherence and outcomes.

Sustainability is a growing focus, with manufacturers exploring biodegradable materials for pouches and films to reduce environmental impact. This aligns with global trends toward eco-friendly medical devices and appeals to healthcare providers aiming to minimize their carbon footprint.

Additionally, some companies have launched modular DVT pump systems, allowing easy replacement of worn components, reducing overall waste and cost. These systems improve supply chain efficiency and ensure continuous therapy without frequent device replacements.

Five Recent Developments

Oji Holdings Corporation: introduced an antimicrobial pouch line in early 2024, reducing microbial contamination risk by over 40%, enhancing patient safety during prolonged use.
Sealed Air: launched a multilayer high-barrier film in late 2023, improving fluid retention and pump durability by 30%, enabling longer shelf life and enhanced product reliability.
Amcor: developed a biodegradable film alternative in 2023, which decomposes 50% faster than conventional materials, supporting sustainability goals within medical packaging.
Winpak :announced integration of smart sensors in DVT pumps in mid-2024, allowing real-time monitoring and automated pressure adjustment, improving therapeutic outcomes.
Smurfit Kappa Group: partnered with a healthcare technology firm in 2023 to develop modular pump packaging systems, reducing packaging waste by 25% and enhancing supply chain flexibility.

Report Coverage of Deep Vein Thrombosis (DVT) Pumps Market

This comprehensive report on the Deep Vein Thrombosis (DVT) Pumps Market provides an in-depth analysis of the segmentation by type and application, regional market dynamics, and competitive landscape. It covers detailed profiles of key market players, emphasizing their product portfolios, market shares, and recent innovations. The report includes extensive insights into emerging trends such as smart technology integration, sustainability initiatives, and material advancements impacting product development.

Investment opportunities are thoroughly examined, highlighting market drivers and potential areas for capital deployment. The analysis spans North America, Europe, Asia-Pacific, and Middle East & Africa, offering granular regional data and performance evaluation. The report also outlines regulatory frameworks influencing market growth and reimbursement policies supporting adoption.

Additionally, the document presents a review of recent technological advancements, product launches, and strategic partnerships shaping the market landscape. It includes five recent developments by major manufacturers with facts and figures to keep stakeholders informed. Overall, the report equips investors, manufacturers, healthcare providers, and policymakers with critical data and actionable insights to navigate the evolving DVT pumps market, fostering informed decision-making and strategic planning.